Our editorial calendar is designed to accommodate information needs and trends in the biotech industry, topics are continuously updated.
The below list of 2025 in-depth reports and webinars is freely accessible to thousands of professionals and decision makers in the biopharma industry.
Labiotech reports offer detailed analysis on specific biotech topics, providing deep insights into particular areas of the industry. Meanwhile, Inpart reports focus on emerging R&D trends, highlighting new technologies and innovations identified through Connect, an intelligent platform managed by STEM experts.
If you are interested in being a sponsor, we invite you to secure your spot through our advertising page. Please note, this schedule is subject to change.
In this podcast, we will explore key highlights from the 43rd Annual J.P. Morgan Healthcare Conference, held in San Francisco from January 13-16, 2025.
Listen to the podcast
This report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.
Download the report
This report aims to provide scientific decision-makers with the most promising, high-impact research and assets in oncology in development by teams in institutes and biotechs around the world.
This report summarises the key research trends in sustainable materials and green chemistry innovation, providing R&D decision makers with high-impact research from institutes worldwide.
Register now
This report explores the latest R&D trends in immunology and inflammation, surfacing the most promising research and assets from leading institutes and biotechs worldwide. Download the report
In this podcast, we will dive into the key highlights from BIO-2025, taking place in Boston, MA, USA, from June 16-19, 2025.
Join us for a webinar on the state of the European biotech landscape in 2025, where we’ll explore the key trends, challenges, and opportunities shaping the industry.
In this podcast, we will explore key highlights from BIO-Europe 2025, held in Vienna from November 3-5, 2025.
This report profiles early-stage research and assets in cell and gene therapies most engaged by industrial teams, providing a snapshot of R&D trends and access to teams developing the platforms and therapeutics of tomorrow.